Latest Personal Injury Lawsuit Against Lipitor Claims Type 2 Diabetes Caused by Statin Use
A woman has filed a personal injury lawsuit against Lipitor manufacturer, Pfizer, Inc, claiming that the statin caused her to develop Type 2 diabetes.
In September 2013, the FDA updated their advice on the statin with a warning: “People being treated with statins may have an increased risk of raised blood sugar levels and the development of Type 2 diabetes.” However, they added that statins can be a necessary part of preventing heart disease in many people.
The latest personal injury suit, filed by plaintiff Karen A. Henning in the US District Court of Minnesota just before Christmas, claims that using Lipitor caused her to develop Type 2 diabetes. She seeks $75,000 in damages for medical expenses.
According to the Lipitor lawsuit, Henning took the drug between July 2002 and December 2006. Henning claimed that in addition to taking Lipitor, she lead a healthy and active lifestyle to help reduce her changes of heart disease. She was also prescribed Zocor starting in December 2006, in addition to Lipitor.
In November of 2008, Henning was diagnosed with Type 2 diabetes. As a result, Henning claims that she is not only at higher risk of heart disease – the very thing Lipitor should have treated – but also at risk for kidney disease, blindness, and neuropathy. Type 2 diabetes is a chronic illness, so Henning will have to undergo regular blood testing and go on a restrictive diet, as well as take other prescribed medications to treat the new illness.
In 2012, several plaintiffs sought to have their personal injury lawsuits against Pfizer centralized into one multidistrict litigation (MDL). The Judicial Panel on Multidistrict Litigation denied the motion, but in January 2014, a group of plaintiffs will try again to create a Lipitor MDL in federal court. More and more patients are filing personal injury lawsuits against the pharmaceutical manufacturer because they have developed Type 2 diabetes after taking Lipitor.
Study in British Medical Journal Links Lipitor to Type 2 Diabetes
Although many doctors say that statins like Lipitor are an important part of regulating cholesterol to prevent heart disease, a study published in the British Medical Journal in May 2013 clearly established a link between Lipitor and Type 2 diabetes. The study showed that women are the highest-risk group.
The FDA approved a change of warning label on Lipitor in February 2012, to reflect the potential link between Lipitor and diabetes. The decision was prompted by a clinical trial in 2011 that showed that patients taking Lipitor had an increased risk of developing Type 2 diabetes, but the study results were written off – the women in the study were, generally, believed to have a predisposition toward Type 2 diabetes anyway, due to high blood sugar, high blood pressure, and other risk factors for Type 2 diabetes being prevalent in people with high cholesterol.
However, the latest study showed clearly that Lipitor specifically, compared to other statin drugs, increased women’s risk of developing Type 2 diabetes. Other statins in the study included Zocor and Crestor. The study showed that female patients taking Lipitor had a 22% increased chance to develop new onset diabetes.
The Strom Law Firm Is Now Investigating Lipitor Cases
Although many doctors believe that the benefits of statins such as Lipitor outweigh the risks, patients who are otherwise healthy disagree. Type 2 diabetes carries the risk of a wide variety of different side effects, including increased risk of heart and blood vessel disease, nerve damage or neuropathy, kidney damage, osteoporosis, Alzheimer’s disease, skin and mouth conditions, and diabetic macular edema, which can lead to blindness.
The attorneys at the Strom Law Firm are currently investigating claims that taking Lipitor is related to development of Type 2 diabetes. There may be a limited time to file a claim, so contact us today for a free consultation. 803.252.4800